Nama Insights

National Health Investors (NHI)

Real Estate · Reit Healthcare Facilities · NYSE

National Health Investors (NHI) is a Real Estate company in the Reit Healthcare Facilities industry. It has a market capitalization of $3.50B and a trailing price-to-earnings ratio of 21.1. Over the most recent reported fiscal year, revenue grew 12.1%. Nama's AI scorecard rates it Hold, 4.5 out of 10. On 12-month momentum it ranks in the trailing band of its market.
AI scorecard
Hold · 4.5/10
The sections balance. As of Nov 7, 2026.
Momentum
Trailing · -15.1% over 12 months ex. last
Bottom 20% of its market on the past year's move.
Shariah screen
Not Shariah Compliant
At least one of the three ratios or the industry test failed.
Off its high
-22.0%
How far the last close sits under the highest price of the past five years.
Market cap$3.50B
Trailing P/E21.1
Price / book2.2
Price / sales8.0
FCF yield—
Dividend yield5.3%
Gross margin97.5%
Operating margin45.4%
Net margin38.6%
Revenue growth (YoY)+12.1%
Revenue growth (3-yr annual)+10.5%
EPS growth (YoY)+0.7%
FCF/share growth (YoY)—
Beta0.5
ExchangeNYSE
SectorReal Estate
IndustryReit Healthcare Facilities

NHI earnings

Next report: Nov 9, 2026 (Q3 2026, EPS estimate $1.51). Beat the EPS estimate in 1 of 4 recent quarters.

QuarterReportedEPSEstimateSurpriseRevenue
Q2 2026 Aug 10, 2026 $1.15 $4.57 -74.8% $121.32M
Q1 2026 May 4, 2026 $0.77 $0.86 -10.5% $115.13M
Q4 2025 Feb 26, 2026 $0.76 $0.80 -5.0% $105.82M
Q3 2025 Nov 6, 2025 $0.69 $0.60 +15.0% $89.85M

NHI analyst price target

Median target $80.00 from 8 analysts, ranging $65.00 – $90.00.

Reit Healthcare Facilities peers

TickerCompanyMarket capP/E
WELL Welltower $179.74B 106.1
VTR Ventas $46.93B 164.3
OHI Omega Healthcare Investors $15.34B 17.6
DOC Healthpeak Properties $14.71B 40.5
AHR American Healthcare REIT $12.62B 103.4
CTRE CareTrust REIT $9.03B 25.1
HR Healthcare Realty Trust $6.66B —
SBRA Sabra Health Care REIT $5.51B 31.9
Explore live NHI data on Nama Insights →

Recent Congressional trades

National Health Investors trades disclosed by members of the US House and Senate under the STOCK Act. See the full Congress trades board →

Member Chamber Trade Amount Disclosed
Gilbert Cisneros House Buy $1,001 - $15,000 Sep 4, 2026
Gilbert Cisneros House Buy $1,001 - $15,000 Feb 13, 2026

NHI FAQ

Is NHI a buy?
Nama's AI scorecard currently rates National Health Investors Hold (4.5 out of 10), a call computed from its profitability, cash generation, growth, valuation and balance sheet. It is a research reading, not investment advice.
What is NHI's P/E ratio?
National Health Investors trades at a trailing price-to-earnings ratio of 21.1.
When does NHI report earnings?
National Health Investors's next scheduled report is on Nov 9, 2026. Analysts expect EPS of $1.51.
What is the NHI price target?
The median analyst price target from 8 analysts is $80.00, with a range of $65.00 – $90.00.
Is NHI Shariah compliant?
Nama's AAOIFI-style screen reads National Health Investors as Not Shariah Compliant. At least one of the three ratios or the industry test failed.
Does NHI pay a dividend?
Yes — National Health Investors's dividend yield is 5.3%.